| pubmed-article:17418570 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17418570 | lifeskim:mentions | umls-concept:C0282552 | lld:lifeskim |
| pubmed-article:17418570 | lifeskim:mentions | umls-concept:C1413189 | lld:lifeskim |
| pubmed-article:17418570 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:17418570 | lifeskim:mentions | umls-concept:C0598631 | lld:lifeskim |
| pubmed-article:17418570 | lifeskim:mentions | umls-concept:C0243076 | lld:lifeskim |
| pubmed-article:17418570 | lifeskim:mentions | umls-concept:C1260969 | lld:lifeskim |
| pubmed-article:17418570 | lifeskim:mentions | umls-concept:C0205099 | lld:lifeskim |
| pubmed-article:17418570 | lifeskim:mentions | umls-concept:C1272745 | lld:lifeskim |
| pubmed-article:17418570 | lifeskim:mentions | umls-concept:C1568489 | lld:lifeskim |
| pubmed-article:17418570 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:17418570 | pubmed:dateCreated | 2007-5-14 | lld:pubmed |
| pubmed-article:17418570 | pubmed:abstractText | DPC168, a benzylpiperidine-substituted aryl urea CCR3 antagonist evaluated in clinical trials, was a relatively potent inhibitor of the 2D6 isoform of cytochrome P-450 (CYP2D6). Replacement of the cyclohexyl central ring with saturated heterocycles provided potent CCR3 antagonists with improved selectivity against CYP2D6. The favorable preclinical profile of DPC168 was maintained in an acetylpiperidine derivative, BMS-570520. | lld:pubmed |
| pubmed-article:17418570 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17418570 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17418570 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17418570 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17418570 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17418570 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17418570 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17418570 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17418570 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17418570 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17418570 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17418570 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17418570 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17418570 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:17418570 | pubmed:issn | 0960-894X | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:DeciccoCarl... | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:DaviesPaulP | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:WackerDean... | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:VarnesJeffrey... | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:KoSoo SSS | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:WelchPatricia... | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:CovingtonMary... | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:StowellNicole... | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:WadmanEric... | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:SolomonKimber... | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:NewtonRobert... | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:CarterPercy... | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:ChristDavid... | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:DasAnuk MAM | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:KarivIlonaI | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:PruittJames... | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:BostromLori... | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:BattDouglas... | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:HoughtonGrego... | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:YeleswaramSwa... | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:McLaughlinEri... | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:VaddiKrishna... | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:GradenDaniell... | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:BookerShon... | lld:pubmed |
| pubmed-article:17418570 | pubmed:author | pubmed-author:OrlovskyYevge... | lld:pubmed |
| pubmed-article:17418570 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17418570 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:17418570 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:17418570 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17418570 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17418570 | pubmed:pagination | 2992-7 | lld:pubmed |
| pubmed-article:17418570 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:17418570 | pubmed:meshHeading | pubmed-meshheading:17418570... | lld:pubmed |
| pubmed-article:17418570 | pubmed:meshHeading | pubmed-meshheading:17418570... | lld:pubmed |
| pubmed-article:17418570 | pubmed:meshHeading | pubmed-meshheading:17418570... | lld:pubmed |
| pubmed-article:17418570 | pubmed:meshHeading | pubmed-meshheading:17418570... | lld:pubmed |
| pubmed-article:17418570 | pubmed:meshHeading | pubmed-meshheading:17418570... | lld:pubmed |
| pubmed-article:17418570 | pubmed:meshHeading | pubmed-meshheading:17418570... | lld:pubmed |
| pubmed-article:17418570 | pubmed:meshHeading | pubmed-meshheading:17418570... | lld:pubmed |
| pubmed-article:17418570 | pubmed:meshHeading | pubmed-meshheading:17418570... | lld:pubmed |
| pubmed-article:17418570 | pubmed:meshHeading | pubmed-meshheading:17418570... | lld:pubmed |
| pubmed-article:17418570 | pubmed:meshHeading | pubmed-meshheading:17418570... | lld:pubmed |
| pubmed-article:17418570 | pubmed:meshHeading | pubmed-meshheading:17418570... | lld:pubmed |
| pubmed-article:17418570 | pubmed:meshHeading | pubmed-meshheading:17418570... | lld:pubmed |
| pubmed-article:17418570 | pubmed:meshHeading | pubmed-meshheading:17418570... | lld:pubmed |
| pubmed-article:17418570 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17418570 | pubmed:articleTitle | CC chemokine receptor-3 (CCR3) antagonists: improving the selectivity of DPC168 by reducing central ring lipophilicity. | lld:pubmed |
| pubmed-article:17418570 | pubmed:affiliation | Bristol-Myers Squibb Pharmaceutical Research Institute, PO Box 4000, Princeton, NJ 08543-4000, USA. | lld:pubmed |
| pubmed-article:17418570 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:17418570 | lld:chembl |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17418570 | lld:pubmed |
